Kymera Therapeutics
KYMR
#4068
Rank
โ‚น183.08 B
Marketcap
โ‚น2,819
Share price
7.67%
Change (1 day)
-5.21%
Change (1 year)

P/S ratio for Kymera Therapeutics (KYMR)

P/S ratio as of April 2025 (TTM): 45.3

According to Kymera Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.55. At the end of 2024 the company had a P/S ratio of 55.2.

P/S ratio history for Kymera Therapeutics from 2020 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202455.2207.01%
202318.0-38.54%
202229.2-34.72%
202144.8-44.69%
202081.0

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA